Valerio Therapeutics's total assets for Q4 2024 were €17.93M, a decrease of -38.89% from the previous quarter. FR:ALVIO total liabilities were €26.19M for the fiscal quarter, a 3.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.